Abbott Laboratories (ABT) stock analysis

ABT · Abbott Laboratories

Latest recorded price: USD 107.52

Model-estimated fair value: USD 52.67. This assumption-based estimate is for general research and is not investment advice.

Sector and industry: Healthcare · Medical Devices

At $107.52, ABT trades 104.2% above the model's base-case value of $52.67. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $39.37 in the conservative case and $67.58 in the optimistic case, with a valuation confidence score of 82/100. About 75% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth 0.5%, free cash flow margin 16.7%, ROIC 8.1%. The model does not flag any risk signals for this company.

Similar companies in Healthcare